Flag in the crossroads: Flagellin modulates innate and adaptive immunity

Current Opinion in Gastroenterology

Volumn 22, Issue 1, 2006, Pages 8-12

  Gewirtz, Andrew T ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Crohn's disease; Epithelial cells; Flagellin; Innate immunity; Salmonella; Toll like receptor 5

Indexed keywords

FLAGELLIN; TOLL LIKE RECEPTOR 5; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR;

COLITIS; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; REVIEW; SEROLOGY; ADAPTATION; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADAPTATION, PHYSIOLOGICAL; BIOLOGICAL MARKERS; CROHN DISEASE; FEMALE; FLAGELLIN; HUMANS; IMMUNITY, NATURAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; PROGNOSIS; RECEPTORS, CELL SURFACE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TOLL-LIKE RECEPTOR 5;

EID: 33644830557     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000194791.59337.28     Document Type: Review

References (25)

1. Nash S, Stafford J, Madara JL. Effects of polymorphonuclear leukocyte transmigration on barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1987; 80:1104-1113.
2. Nash S, Parkos CA, Nusrat A, et al. In vitro model of intestinal crypt abcess: a novel neutrophil-derived secretagogue activity. J Clin Invest 1991; 87:1474-1477.
3. McCormick BA, Colgan SP, Archer CD, et al. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 1993; 123:895-907.
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521-533.
5. Gewirtz AT, Simon PO Jr, Schmitt CK, et al. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest 2001; 107:99-109.
6. McSorley SJ, Ehst BD, Yu Y, Gewirtz AT. Bacterial flagellin is an effective adjuvant for CD4(+) T cells in vivo. J Immunol 2002; 169:3914-3919.
7. Gewirtz AT. Intestinal epithelial toll-like receptors: to protect. And serve? Curr Pharm Des 2003; 9:1-5.
8. Zeng H, Carlson AQ, Guo Y, et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 2003; 171:3668-3674.
9. Mizel SB, West AP, Hantgan RR. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 2003; 278:23624-23629.
10. Gewirtz AT, Navas TA, Lyons S, et al. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882-1885.
11. Lyons S, Wang L, Casanova JE, et al. Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway. J Cell Sci 2004; 117:5771-5780. This study determined the mechanism and key bacterial determinant that permit a pathogen to activate basolateral TLR5, thus resulting in epithelial proinflammatory gene expression.
12. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 2002; 292:185-193.
13. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122:44-54.
14. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27:721-726.
15. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113:1296-1306. This study used unbiased technique to define Crohn's disease antigens and revealed a dominant role for flagellin. This work further showed that immunoreactivity to flagellin was sufficient to lead to colitis in susceptible mice and correlated with disease in humans.
16. ••] in observing that flagellin immunoreactivity in humans exhibits broad specificity.
17. Yonekura K, Maki-Yonekura S, Namba K. Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy. Nature 2003; 424:643-650.
18. Cookson BT, Bevan MJ. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol 1997; 158:4310-4319.
19. McSorley SJ, Cookson BT, Jenkins MK. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J Immunol 2000; 164:986-993.
20. Sanders CJ, Moore DA, Williams IR, Gewirtz AT. Non-hematopoietic cells link innate and adaptive immune responses to bacterial flagellin via early cytokine production. FASEB J 2005; 19:A939.
21. Gewirtz AT, Kumar MV, Brant SR, et al. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Gastroenterology 2005; 128:55A.
22. Means TK, Hayashi F, Smith KD, et al. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 2003; 170:5165-5175.
23. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115:66-75. Important work showing immune cells in the gut have a very different phenotype than those isolated from blood.
24. Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198:1563-1572.
25. Hackett J, Attridge S, Rowley D. Oral immunization with live, avirulent fla+ strains of Salmonella protects mice against subsequent oral challenge with Salmonella typhimurium. J Infect Dis 1988; 157:78-84.